Prosecution Insights
Last updated: October 01, 2026

Examiner: GRAY, PHILLIP A

Tech Center 3700 • Art Units: 2841 3763 3767 3783

This examiner grants 74% of resolved cases

Analysis

Phillip A. Gray is an examiner in Tech Center 3700, working within Art Unit 2841. He has resolved 915 cases, providing a robust dataset for analyzing his examination patterns. The examiner maintains an allowance rate of 74.3%, which serves as a primary indicator of the likelihood of success for applicants. Furthermore, the data reveals a 10.5% interview lift, suggesting that oral advocacy can play a helpful role in securing an allowance.

The median days to allowance for applications under his review is 1461. This 1461-day timeline reflects a longer prosecution period for cases in Art Unit 2841. Given the 10.5% interview lift, practitioners might find that scheduling an interview is a strategic move to address rejections and potentially improve the 74.3% allowance rate. With 915 resolved cases, the examiner has a well-established history that applicants can use to benchmark their own progress in Tech Center 3700.

In this environment, the 74.3% allowance rate and 1461-day median pendency are key factors for applicants to consider. The 10.5% interview lift offers a way to potentially navigate the process more effectively. These metrics provide a valuable guide for practitioners working with Examiner Gray.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

74.4%
Allow Rate
+4.4% vs TC avg
941
Total Applications
+10.5%
Interview Lift
1459
Avg Prosecution Days
Based on 917 resolved cases, 2023–2026

Rejection Statute Breakdown

0.5%
§101 Eligibility
32.5%
§102 Novelty
52.7%
§103 Obviousness
11.9%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18452096 MEANS AND METHODS FOR IMPLANTING CELLS SECRETING A THERAPEUTIC COMPOUND Non-Final OA Roche Diabetes Care, Inc.
18565568 LIQUID DRUG TRANSPORT DEVICE, LIQUID DRUG TRANSPORT SYSTEM, AND LIQUID DRUG TRANSPORT METHOD Final Rejection TOHOKU UNIVERSITY
18324916 FORKED PHACOEMULSIFICATION NEEDLE Final Rejection Johnson & Johnson Surgical Vision, Inc.
18109039 Cardiopulmonary Resuscitation Catheter and Related Systems and Methods Final Rejection Regents of the University of Minnesota
18528986 ELECTROSURGICAL PROBE AND ELECTRODE ASSEMBLY WITH LAYERED ELECTRODE FEATURES Final Rejection Arthrex, Inc.
18618839 Catheter Clearing System and Methods Non-Final OA C. R. Bard, Inc.
18248031 DELIVERY DEVICE AND COATED NEEDLE OR CANNULA Non-Final OA Becton, Dickinson and Company
18705856 USER EQUIPMENT, ELECTRONIC SYSTEM, DRUG DELIVERY DEVICE, METHOD, MACHINE-READABLE CODE, DATA STORAGE MEDIUM, AND SET Non-Final OA Sanofi
18305751 Medicament Delivery Device Final Rejection Sanofi
18627309 CELLULAR TRANSPLANT CARRIER DEVICES AND METHODS OF USING THE SAME Non-Final OA THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE
18159970 REMOVABLE DUAL FUNCTION LOADING TOOL & PROTECTOR FOR DRUG COATED MEDICAL DEVICES Non-Final OA Cook Medical Technologies LLC
18696096 CATHETERS WITH GUIDEWIRE ADAPTORS AND RELATED METHODS Non-Final OA B. BRAUN MELSUNGEN AG

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month